221 related articles for article (PubMed ID: 35579819)
21. Comparison of three methods (an updated logistic probabilistic method, the Naranjo and Liverpool algorithms) for the evaluation of routine pharmacovigilance case reports using consensual expert judgement as reference.
Théophile H; André M; Miremont-Salamé G; Arimone Y; Bégaud B
Drug Saf; 2013 Oct; 36(10):1033-44. PubMed ID: 23828659
[TBL] [Abstract][Full Text] [Related]
22. Training Augmented Intelligent Capabilities for Pharmacovigilance: Applying Deep-learning Approaches to Individual Case Safety Report Processing.
Abatemarco D; Perera S; Bao SH; Desai S; Assuncao B; Tetarenko N; Danysz K; Mockute R; Widdowson M; Fornarotto N; Beauchamp S; Cicirello S; Mingle E
Pharmaceut Med; 2018; 32(6):391-401. PubMed ID: 30546259
[TBL] [Abstract][Full Text] [Related]
23. Validation of a Novel Method to Assess the Clinical Quality of Information in Pregnancy-Related Pharmacovigilance Case Reports: A ConcePTION Project.
van Rijt-Weetink YRJ; Egberts TCG; van Hunsel FPAM; Lewis DJ; Yates LM; Winterfeld U; van Puijenbroek EP
Drug Saf; 2024 Mar; 47(3):261-270. PubMed ID: 38183608
[TBL] [Abstract][Full Text] [Related]
24. Identification of Substandard Medicines via Disproportionality Analysis of Individual Case Safety Reports.
Trippe ZA; Brendani B; Meier C; Lewis D
Drug Saf; 2017 Apr; 40(4):293-303. PubMed ID: 28130773
[TBL] [Abstract][Full Text] [Related]
25. A Pilot, Predictive Surveillance Model in Pharmacovigilance Using Machine Learning Approaches.
De Abreu Ferreira R; Zhong S; Moureaud C; Le MT; Rothstein A; Li X; Wang L; Patwardhan M
Adv Ther; 2024 Jun; 41(6):2435-2445. PubMed ID: 38704799
[TBL] [Abstract][Full Text] [Related]
26. Contribution of Causality Assessment for an Automated Detection of Safety Signals: An Example Using the French Pharmacovigilance Database.
Berbain T; Pariente A; Miremont-Salamé G; Grandvuillemin A; Micallef J; Chouchana L; Benkebil M; Théophile H;
Drug Saf; 2020 Mar; 43(3):243-253. PubMed ID: 31974775
[TBL] [Abstract][Full Text] [Related]
27. Finding Needles in the Haystack: Clinical Utility Score for Prioritisation (CUSP), an Automated Approach for Identifying Spontaneous Reports with the Highest Clinical Utility.
Kara V; Powell G; Mahaux O; Jayachandra A; Nyako N; Golds C; Bate A
Drug Saf; 2023 Sep; 46(9):847-855. PubMed ID: 37535258
[TBL] [Abstract][Full Text] [Related]
28. Causality assessment in pharmacovigilance: The French method and its successive updates.
Miremont-Salamé G; Théophile H; Haramburu F; Bégaud B
Therapie; 2016 Apr; 71(2):179-86. PubMed ID: 27080836
[TBL] [Abstract][Full Text] [Related]
29. Automation Opportunities in Pharmacovigilance: An Industry Survey.
Ghosh R; Kempf D; Pufko A; Barrios Martinez LF; Davis CM; Sethi S
Pharmaceut Med; 2020 Feb; 34(1):7-18. PubMed ID: 32036574
[TBL] [Abstract][Full Text] [Related]
30. Comparison of different methods for causality assessment of adverse drug reactions.
Behera SK; Das S; Xavier AS; Velupula S; Sandhiya S
Int J Clin Pharm; 2018 Aug; 40(4):903-910. PubMed ID: 30051231
[TBL] [Abstract][Full Text] [Related]
31. Pharmacovigilance in ophthalmology in Switzerland: an analysis of the most frequently reported ocular adverse drug reactions within the last 25 years.
Karrer JE; Giovannoni L; Kullak-Ublick GA; Weiler S
Swiss Med Wkly; 2019 Jun; 149():w20085. PubMed ID: 31256417
[TBL] [Abstract][Full Text] [Related]
32. Comparative Assessment of the National Pharmacovigilance Systems in East Africa: Ethiopia, Kenya, Rwanda and Tanzania.
Barry A; Olsson S; Minzi O; Bienvenu E; Makonnen E; Kamuhabwa A; Oluka M; Guantai A; Bergman U; van Puijenbroek E; Gurumurthy P; Aklillu E
Drug Saf; 2020 Apr; 43(4):339-350. PubMed ID: 31919794
[TBL] [Abstract][Full Text] [Related]
33. Key elements in adverse drug interaction safety signals: an assessment of individual case safety reports.
Strandell J; Norén GN; Hägg S
Drug Saf; 2013 Jan; 36(1):63-70. PubMed ID: 23315297
[TBL] [Abstract][Full Text] [Related]
34. Adverse drug reactions at adverse drug reaction monitoring center in Raipur: Analysis of spontaneous reports during 1 year.
Singh P; Agrawal M; Hishikar R; Joshi U; Maheshwari B; Halwai A
Indian J Pharmacol; 2017; 49(6):432-437. PubMed ID: 29674797
[TBL] [Abstract][Full Text] [Related]
35. Impact of adverse event reports from marketing authorization holder-sponsored patient support programs on the performance of signal detection in pharmacovigilance.
Lee I; Lee TA; Crawford SY; Kilpatrick RD; Calip GS; Jokinen JD
Expert Opin Drug Saf; 2020 Oct; 19(10):1357-1366. PubMed ID: 32662668
[TBL] [Abstract][Full Text] [Related]
36. Agreement of expert judgment in causality assessment of adverse drug reactions.
Arimone Y; Bégaud B; Miremont-Salamé G; Fourrier-Réglat A; Moore N; Molimard M; Haramburu F
Eur J Clin Pharmacol; 2005 May; 61(3):169-73. PubMed ID: 15827761
[TBL] [Abstract][Full Text] [Related]
37. Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports.
Conte C; Rousseau V; Vert C; Montastruc F; Montastruc JL; Durrieu G; Olivier P
Fundam Clin Pharmacol; 2020 Aug; 34(4):518-520. PubMed ID: 32022302
[TBL] [Abstract][Full Text] [Related]
38. A Risk-Based Approach for Safety Case Follow-up of Adverse Event Reports in Pharmacovigilance.
Vemula GK; Badale P; Mavrogenis P; Lalande-Luesink I; Borkowski M; Lewis DJ
Adv Ther; 2024 Jan; 41(1):82-91. PubMed ID: 37919600
[TBL] [Abstract][Full Text] [Related]
39. Network Analysis for Signal Detection in Spontaneous Adverse Event Reporting Database: Application of Network Weighting Normalization to Characterize Cardiovascular Drug Safety.
Pétervári M; Benczik B; Balogh OM; Petrovich B; Ágg B; Ferdinandy P
Drug Saf; 2022 Nov; 45(11):1423-1438. PubMed ID: 36198930
[TBL] [Abstract][Full Text] [Related]
40. Artificial Intelligence Within Pharmacovigilance: A Means to Identify Cognitive Services and the Framework for Their Validation.
Mockute R; Desai S; Perera S; Assuncao B; Danysz K; Tetarenko N; Gaddam D; Abatemarco D; Widdowson M; Beauchamp S; Cicirello S; Mingle E
Pharmaceut Med; 2019 Apr; 33(2):109-120. PubMed ID: 31933254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
